Form 4: Columbia Financial exec adds shares via plan
Insider Transaction
SEVP Allyson Katz Schlesinger acquired 22.2191 phantom shares at $15.06 via a stock-based deferral plan and reported updated equity and option holdings.
Summary
- On 2025-11-14, SEVP & Head of Consumer Banking Allyson Katz Schlesinger acquired 22.2191 phantom stock units at $15.06 through the Columbia Bank Stock Based Deferral Plan; total units in this plan now 13,481.9241.
- No sales were reported; the transaction was a non-discretionary purchase by the trustee of a rabbi trust tied to the stock-based deferral plan, with units to be settled in shares upon distribution.
- Reported common stock holdings: 64,281 shares direct; indirect holdings include ESOP (6,683), SERP (6,459), SIM (4,683), and unvested/contingent awards Stock Award II (14,470), Stock Award III (12,672), Stock Award IV (12,288).
- Options outstanding: 155,294 @ $15.6 (fully vested; exp. 2029-07-23); 12,632 @ $15.94 (vesting in three installments from 2024-05-01; exp. 2033-05-01); 9,292 @ $16.49 (vesting from 2025-03-06; exp. 2034-03-06); 21,289 @ $16.23 (vesting from 2026-03-03; exp. 2035-03-03).
- Performance-based vesting applies to 75% of certain stock awards and to Stock Award IV overall; if achieved, Stock Award IV would vest on 2028-03-03. The filing was signed by Power of Attorney on 2025-11-18.
Sentiment
Score: 6
Explanation: Slightly positive: incremental insider accumulation and transparent equity schedules, with no sales reported; impact on valuation is minimal.
Positives
- Incremental insider acquisition under a stock-based deferral plan aligns executive interests with shareholders.
- A large option grant (155,294 shares at $15.6) is fully vested and exercisable, adding clarity to potential exercisable equity.
- Clearly disclosed vesting schedules for options and awards support transparency on future equity delivery timing.
Negatives
- A substantial portion of the reported equity consists of unvested or performance-contingent awards, which may not convert to shares if conditions are not met.
- Significant option overhang (total options reported: 198,507) could contribute to future dilution if exercised.
Risks
- 75% of certain stock awards vest only upon achievement of specified performance-based criteria; unvested awards may not vest if criteria are not met.
Future Outlook
Equity awards continue to vest on disclosed schedules, with a substantial portion contingent on meeting specified performance criteria; phantom units in the deferral plan will be settled in shares upon distribution.
Industry Context
Routine non-discretionary insider acquisitions via deferral plans and the use of multi-year, performance-based equity awards and 10-year options are standard compensation practices among U.S. regional banks.
Comparison to Industry Standards
- Compensation structure (time-based and performance-based stock awards, plus 10-year options) aligns with peers such as Provident Financial Services (PFS), Valley National Bancorp (VLY), and Lakeland Bancorp (LBAI), which commonly use three-year ratable vesting and performance-conditioned equity.
- Use of a rabbi trust and stock-based deferral plan mirrors common executive deferral programs at regional banks, supporting tax-efficient alignment and long-term retention.
- Option exercise prices in the mid-teens and multi-year vesting schedules are typical for regional bank equity plans established in the late 2010s.
Stakeholder Impact
- Minimal immediate impact to shareholders due to the small size of the acquisition.
- Demonstrates ongoing alignment of senior executive incentives with long-term shareholder value through equity-based compensation.
- Potential long-term dilution from option exercises and vesting of awards, consistent with standard equity incentive practices.
Next Steps
- Time-based vesting to continue on previously disclosed schedules for Stock Awards II and III.
- Performance-based outcomes to determine vesting for the remaining 75% of certain awards and for Stock Award IV (target vesting date 2028-03-03 if achieved).
- Options continue to vest per schedules beginning 2024-05-01, 2025-03-06, and 2026-03-03 until fully vested or expired.
Key Dates
| Date | Description |
|---|---|
| 2020-07-23 | Stock options (155,294 @ $15.6) fully vested and exercisable; expiration 2029-07-23. |
| 2024-05-01 | Vesting commences for certain stock awards (25% in three installments) and for options (12,632 @ $15.94; exp. 2033-05-01). |
| 2025-03-03 | Stock Award IV grant date; performance-based vesting, if achieved, would occur three years later on 2028-03-03. Options tranche dated 2026-03-03 begins vesting on this schedule; exp. 2035-03-03. |
| 2025-03-06 | Vesting commences for Stock Award III (25% in three installments) and options (9,292 @ $16.49; exp. 2034-03-06). |
| 2025-11-14 | Earliest transaction date; 22.2191 phantom units acquired at $15.06. |
| 2025-11-18 | Form signed by Power of Attorney. |
| 2026-03-03 | Date exercisable for options (21,289 @ $16.23); expiration 2035-03-03. |
| 2028-03-03 | Potential vesting date for Stock Award IV if performance criteria are achieved. |
| 2029-07-23 | Expiration of 2020 option grant (155,294 @ $15.6). |
| 2033-05-01 | Expiration of options (12,632 @ $15.94). |
| 2034-03-06 | Expiration of options (9,292 @ $16.49). |
| 2035-03-03 | Expiration of options (21,289 @ $16.23). |
Keywords
Columbia Financial, CLBK, Form 4, insider transaction, phantom stock, rabbi trust, Stock-Based Deferral Plan, 2019 Equity Incentive Plan, stock options, performance-based vesting, ESOP, SERP, SIM, executive compensation, regional bank
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.